| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |